Clinical Trial Update: Neoadjuvant Therapy of PD-1 Blockade Combined With Chemotherapy for Esophageal Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

A combined neoadjuvant PD-1 blockade with chemotherapy trial for esophageal carcinoma is in Phase 1/2 with unclear status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Carcinoma

Snippet

Sponsor: Beijing Friendship Hospital | Conditions: Esophageal Carcinoma, Neoadjuvant Immunotherapy | Phase 1, Phase 2 | Status: UNKNOWN